Kawasaki disease complicated with Coronary Artery Aneurysm
Conditions
Interventions
Kawasaki disease only coronary artery dilatation group:None
Kawasaki disease without coronary artery lesion group:None
Kawasaki disease complicated with coronary artery aneurysm group:None
Sponsors
Children's Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Cases that conform to the routine diagnosis and treatment of Kawasaki disease; 2. The diagnostic criteria for Kawasaki disease patients admitted from January 2015 to August 2017 were all in line with the "Diagnosis, Treatment and Long-Term Follow-up of Kawasaki Disease" statement issued by the AHA in 2004. The diagnostic criteria for Kawasaki disease patients admitted from September 2017 to December 2019 all conformed to the "Diagnosis, Treatment and Long-Term Follow-up of Kawasaki Disease" statement issued by the AHA in 2017, including both complete and incomplete Kawasaki disease. 3. Hospitalized children with complete medical history, blood biochemical test results and echocardiographic examination results; 4.After the diagnosis of Kawasaki disease, IVIG at a dose of 2 g/kg and oral aspirin are routinely used for treatment.
Exclusion criteria
Exclusion criteria: 1.Other febrile rash illnesses, such as sepsis, toxic shock syndrome caused by streptococcal or staphylococcal infections, and scarlet fever. 2.Confirmed infections caused by enteroviruses, adenoviruses, measles viruses, Epstein-Barr viruses, mycoplasmas, rickettsiae, and spirochetes. 3.Cases with allergic and rheumatic diseases; 4.incomplete clinical baseline data;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Demographic information;Treatment plan;Clinical diagnostic data;Laboratory parameters;Cardiac ultrasound results before IVIG treatment: diameters of RCA, LCA and LAD and their Z values; | — |
Countries
China
Contacts
Public ContactYi Qijian
Children's Hospital of Chongqing Medical University
Outcome results
None listed